Version 5.4
Homo sapiens Gene: LGALS14
Summary
InnateDB Gene IDBG-50731.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol LGALS14
Gene Name lectin, galactoside-binding, soluble, 14
Synonyms
Species Homo sapiens
Ensembl Gene ENSG00000006659
Encoded Proteins
IDBP-50733
lectin, galactoside-binding, soluble, 14
IDBP-246444
lectin, galactoside-binding, soluble, 14
IDBP-765745
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene is predominantly expressed in placenta. The encoded protein belongs to the galectin (galaptin/S-lectin) family. The members of galectin family contain one or two carbohydrate recognition domains, which can bind beta-galactoside. Two alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]
Gene Information
Type Protein coding
Genomic Location Chromosome 19:39704306-39709444
Strand Forward strand
Band q13.2
Transcripts
ENST00000360675 ENSP00000353893
ENST00000392052 ENSP00000375905
ENST00000601802 ENSP00000471660
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
GO:0030246 carbohydrate binding
Biological Process
GO:0006915 apoptotic process
Cellular Component
GO:0005634 nucleus
Orthologs
No orthologs found for this gene
Cross-References
SwissProt
TrEMBL
UniProt Splice Variant
Entrez Gene
UniGene Hs.24236
RefSeq NM_020129 NM_203471
HUGO
OMIM
CCDS CCDS12542 CCDS46073
HPRD 06268
IMGT
EMBL
GenPept
RNA Seq Atlas

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca